Johnson & Johnson asks US regulators to OK its one-shot COVID-19 vaccine

Johnson & Johnson has asked U.S. regulators to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.

Posted: Feb 4, 2021 5:28 PM
Updated: Feb 4, 2021 5:35 PM

Johnson & Johnson has asked U.S. regulators to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.

Preliminary results from a massive study showed J&J’s vaccine was safe and offered strong protection against moderate to severe COVID-19. It didn’t appear quite as strong as two-dose competitors made by Pfizer and Moderna.

The company filed an application with the Food and Drug Administration on Thursday.

An FDA panel will meet and pore over the results.

Huntsville
Clear
33° wxIcon
Hi: 44° Lo: 31°
Feels Like: 33°
Florence
Clear
37° wxIcon
Hi: 46° Lo: 29°
Feels Like: 37°
Fayetteville
Clear
31° wxIcon
Hi: 43° Lo: 31°
Feels Like: 31°
Decatur
Clear
31° wxIcon
Hi: 46° Lo: 32°
Feels Like: 31°
Scottsboro
Partly Cloudy
33° wxIcon
Hi: 45° Lo: 31°
Feels Like: 33°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

 

Community Events